WALTHAM, Mass., July 28, 2008 (PRIME NEWSWIRE) -- OXiGENE, Inc. (Nasdaq:OXGN) (Stockholm:OXGN), a clinical-stage, biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, will report second quarter 2008 results on Monday, August 4, 2008. A conference call and webcast hosted by OXiGENE management will begin at 2:00 p.m. EDT (11:00 a.m. PDT).
